Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Taiwan-based firm Vetnostrum is aiming to diversify its portfolio of veterinary generics in the near future, by moving further into the companion animal sector.
Dutch veterinary generics firm Dopharma is to make a significant addition to its manufacturing capabilities by purchasing assets from Boehringer Ingelheim.
Irish veterinary generics specialist Chanelle has opened a new €10 million ($11.6 million) manufacturing facility at its headquarters in Loughrea, Galway.
Piedmont Animal Health and Norbrook Laboratories are among several firms to have gained recent product approvals from the US FDA.
Animal Pharm is looking for new authors for its animal health industry reports team.
UK firm Animalcare has pencilled a fourth-quarter launch date for its recently-approved Cortacare canine dermatology product.
Belgian veterinary generics firm Ecuphar is set to receive European approval for Cortacare – a cutaneous spray solution for dogs.
The European Group for Generic Veterinary Medicines (EGGVP) has reacted warily to the approval of new legislation designed to stimulate the animal health industry.
Sales of veterinary generics have shown healthy growth in the past two years, according to industry association data.
The animal health division of Slovenian pharmaceutical company Krka returned to a dip in sales during the first quarter of 2018.
A large-scale healthcare acquisition, which features a portfolio of veterinary generics, has been terminated.
Alivira Animal Health has gained a considerable manufacturing footprint in Europe by purchasing a subsidiary from a fellow Indian veterinary medicines firm.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.